1. Home
  2. TRAW

as 05-29-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.

Founded: 1998 Country:
United States
United States
Employees: N/A City: NEWTOWN
Market Cap: 15.7M IPO Year: 2013
Target Price: N/A AVG Volume (30 days): 121.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.87 EPS Growth: N/A
52 Week Low/High: $0.55 - $1.26 Next Earning Date: 05-15-2024
Revenue: $226,000 Revenue Growth: N/A
Revenue Growth (this year): -9.73% Revenue Growth (next year): 50.00%

Share on Social Networks: